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Introduction: Our meta-analysis indicated that aging influences the outcomes of acute
pancreatitis (AP), however, a potential role for comorbidities was implicated, as well.
Here, we aimed to determine how age and comorbidities modify the outcomes in AP in
a cohort-analysis of Hungarian AP cases.
Materials and Methods: Data of patients diagnosed with AP by the revised Atlanta
criteria were extracted from the Hungarian Registry for Pancreatic Patients. Outcomes
of interest were mortality, severity, length of hospitalization, local, and systemic
complications of AP. Comorbidities were measured by means of Charlson Comorbidity
Index (CCI) covering pre-existing chronic conditions. Non-parametric univariate and
multivariate statistics were used in statistical analysis. Odds ratios (ORs) with 95%
confidence intervals (CIs) were calculated.
Results: A total of 1203 patients from 18 centers were included. Median age at
admission was 58 years (range: 18–95 years), median CCI was 2 (range: 0–10). Only
severe comorbidities (CCI≥ 3) predicted mortality (OR = 4.48; CI: 1.57–12.80). Although
severe comorbidities predicted AP severity (OR = 2.10, CI: 1.08–4.09), middle (35–
64 years) and old age (≥65 years) were strong predictors with borderline significance,
as well (OR = 7.40, CI: 0.99–55.31 and OR = 6.92, CI: 0.91–52.70, respectively).
Similarly, middle and old age predicted a length of hospitalization ≥9 days. Interestingly,
the middle-aged patients (35–64 years) were three times more likely to develop
pancreatic necrosis than young adults (OR = 3.21, CI: 1.26–8.19), whereas the old-
aged (≥65 years) were almost nine times more likely to develop systemic complications
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than young adults (OR = 8.93, CI: 1.20–66.80), though having severe comorbidities
(CCI ≥ 3) was a predisposing factor, as well.
Conclusion: Our results proved that both aging and comorbidities modify the outcomes
of AP. Comorbidities determine mortality whereas both comorbidities and aging predict
severity of AP. Regarding complications, middle-aged patients are the most likely to
develop local complications; in contrast, those having severe comorbidities are prone
to develop systemic complications. Studies validating the implementation of CCI-based
predictive scores are awaited.
Keywords: acute pancreatitis, comorbidities, mortality, severity, length of hospitalization, complications,
prediction, Charlson Comorbidity Index
INTRODUCTION
The annual incidence of AP ranges from 10 to 100 cases per
100,000 persons (Roberts et al., 2013), showing an increasing
tendency throughout the past decades (Yadav and Lowenfels,
2013). Multiple theories have been proposed to explain the
increment: better diagnostics (e.g., general access to the
measurement of pancreatic enzymes) (Yadav et al., 2011), lifestyle
factors (e.g., obesity, alcohol consumption, and tobacco use)
(Alsamarrai et al., 2014; Samokhvalov et al., 2015) as well as aging
of the population (Spanier et al., 2013) have been implicated.
Aging not only increases the risk of AP (Yadav and Lowenfels,
2013) but also may change the clinical course of it, resulting
in higher mortality (Fan et al., 1988; Spanier et al., 2013)
and longer hospitalization (Murata et al., 2011; McNabb-Baltar
et al., 2014), thereby increases the cost for care in the elderly
(Fagenholz et al., 2007; Murata et al., 2012). Accordingly, widely
accepted predictive scores and severity indices, such as Ranson
criteria (age > 55 years) (Ranson et al., 1974), APACHE II
(age > 44 years) (Larvin and McMahon, 1989), and BISAP
(age > 60 years) (Wu et al., 2008) consider age as a risk
factor of worse clinical outcomes, where the potential impact of
comorbidities is omitted from these.
Risk of morbidities increases with age (Vasilopoulos et al.,
2014). Since the average age of AP onset is around 55–70 years
(Yadav and Lowenfels, 2013; Hamada et al., 2014), most AP
patients are exposed to the burden of comorbidities (Murata et al.,
2015). Sporadic studies reported on how comorbidities affect the
outcomes of AP: they increases mortality (Singla et al., 2009;
Murata et al., 2011, 2015; Akshintala et al., 2013; McNabb-Baltar
et al., 2014) and the length of hospital stay, as well (Murata et al.,
2011, 2015; Francisco et al., 2013). However, the predictive role
of comorbidities is underutilized regarding AP severity and the
development of complications.
Results of the meta-analysis by Marta et al. (under revision)
published in the previous issue of Frontiers Science suggested
that both mortality and severity of AP are age-dependent, but age
alone does not explain the increment of mortality in the elderly.
This increment might be attributed to comorbidities, as shown
Abbreviations: AP, acute pancreatitis; APACHE, Acute Physiology and Chronic
Health Evaluation; BISAP, Bedside Index of Severity in Acute Pancreatitis;
CCI, Charlson Comorbidity Index; CI, confidence interval; LOH, length of
hospitalization; OR, odds ratio.
in Figure 11 by Marta et al. (under revision). These findings
inspired us to conduct a cohort-analysis of AP cases to provide
a comprehensive assessment on how aging and comorbidities
alter outcomes of AP including mortality, severity, LOH, and
complications; and to decide whether the burden of aging or
comorbidities is decisive for determining hard outcomes.
MATERIALS AND METHODS
Population
We extracted data from the Hungarian Registry for Pancreatic
Patients (AP Registry) established in 2011 by the Hungarian
Pancreatic Study Group in order to advance clinical care
and research in Pancreatology (Parniczky et al., 2016). AP
Registry contains data on consecutive cases of AP attending
several Hungarian centers between 2011 and 2017. Accuracy
of data recorded is secured by a four-level quality check
system involving both medical administrative personnel and
gastroenterologist specialists.
Comorbidities
Registry forms of AP cases involve an admission form (A form)
and follow-up forms (B-forms) covering the entire hospital stay,
as well as the de-identified electronic discharge files. All files
were carefully reviewed by an author with a medical degree
to aggregate CCI (Charlson et al., 1987) with the International
Classification of Diseases 9/10 coding algorithm (Quan et al.,
2005). No search engines were used when reviewing charts. CCI
items were dedicated to rating common chronic pre-existing
diseases along 19 health-related (groups of) conditions. Every
CCI item has a weight according to the severity of comorbidities
covered (Charlson et al., 1987). CCI of each case was calculated
by compiling the weighted items. Earlier studies proved that
CCI is an effective predictor of hard outcomes in several acute
and chronic conditions (Ng et al., 2013; Frenkel et al., 2014;
Marventano et al., 2014).
Eligibility Criteria
To be included in analysis, the following criteria should be met:
(1) Diagnosis of AP (“Two out of three”) (Working Group
Iap/Apa Acute Pancreatitis Guidelines, 2013):
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(i) Abdominal pain
(ii) Serum amylase and/or lipase greater than three times the
upper normal limit
(iii) Characteristic findings on abdominal cross-sectional
imaging
(2) Age ≥ 18 years
(3) Available history for CCI (Charlson et al., 1987)
Outcomes
Our AP-related outcomes included in-hospital mortality,
severity, LOH, local complications (including peripancreatic
fluid collections, pseudocysts, and pancreatic necrosis), and
organ failure (including respiratory, renal, and cardiac failure).
Ethical Approval
AP Registry has been approved by Scientific and Research Ethics
Committee of the Medical Research Council, Hungary (22254-
1/2012/EKU). All subjects gave written informed consent in
accordance with the Declaration of Helsinki.
Statistical Analysis
An expert biostatistician carried out the analysis with SPSS 19.0.0
(IBM Analytics, United States). Case numbers and percentages
were calculated for categorical variables, medians with 25%
and 75% quartiles (Q1 and Q3, respectively) and ranges were
computed for numerical variables in descriptive analysis (due to
non-normal distribution of data indicated by the Kolmogorov–
Smirnov test). In all analysis, a probability (p) < 0.05 indicated
a significant difference, whereas a p-value between 0.05 and 0.10
indicated borderline significance.
Representativeness of study population was tested by
binomial, one sample median, and Goodness-of-fit χ2 tests.
In univariate analysis, Spearmann’s rho was calculated to
explore correlations between age, CCI, and LOH. ORs with 95%
CIs were calculated from 2 × 2 tables. If OR was not calculable,
association were investigated with χ2 - or Fisher’s tests.
In multivariate analysis, binary logistic and multinominal
regressions were used to investigate the joint effect of age
categories and CCI categories or that of age categories and
individual comorbidities. We used a three-level age-stratification
(young-aged between 18 and 34 years of age, middle-aged
between 35 and 64 years of age, and old-aged ≥ 65 years of age)
and a four-level comorbidity stratification (none if CCI = 0, mild
if CCI = 1, moderate if CCI = 2, and severe if CCI ≥ 3).
RESULTS
Demography
AP Registry contained 1241 cases, of them 1203 (96.9%) from
18 centers were eligible for inclusion. Demography of study
population and that of AP Registry are presented in Table 1
and Supplementary Appendix 1, respectively. Distribution of
sites of recruitment is presented in Supplementary Appendix 1.
Study population proved to be representative to that of AP
Registry regarding demography and disease outcomes (p > 0.05
TABLE 1 | Demography of study population including a total of 1203 cases of
acute pancreatitis (AP).
Age, median (Q1–Q3) 58 (44–70)
Sex, nmale (%male) 670 (55.7)
Etiology (pure)
Biliary, n (%) 528 (43.9)
Alcoholic, n (%) 269 (22.4)
Hypertriglyceridemic, n (%) 69 (5.7)
Mortality, n (%) 28 (2.3)
Severity of pancreatitis
Mild, n (%) 825 (68.6)
Moderate, n (%) 313 (26.0)
Severe, n (%) 65 (5.4)
Length of hospitalization, median (Q1–Q3) 9 (7–14)
Local complications, n (%) 358 (29.8)
Fluid collection, n (%) 303 (25.2)
Pseudocyst, n (%) 120 (10.0)
Necrosis, n (%) 111 (9.2)
Systemic complications, n (%) 92 (7.7)
Respiratory failure, n (%) 55 (4.6)
Heart failure, n (%) 19 (1.6)
Renal failure, n (%) 33 (2.7)
Charlson Comorbidity Index, median (Q1–Q3) 2 (0–2)
Severity of comorbidities
No comorbidities, n (%) 444 (36.9)
Mild comorbidities, n (%) 345 (28.7)
Moderate comorbidities, n (%) 190 (15.8)
Severe comorbidities, n (%) 224 (18.6)
Continuous variables are presented in median with quartiles (Q1–Q3), categorical
variables are presented in frequencies (n) with percentages of total (%).
for all variables analyzed) (Supplementary Appendices 2, 9).
Data quality for all variables was >99% in study population
(Supplementary Appendix 3).
Association Between Aging and
Comorbidities in AP
Aging Strongly Influences the Outcomes of AP in
Univariate Models
Median age on admission was 58 years (Q1–Q3: 44–70 years,
range: 18–95 years) (Figure 1A). Deceased were older than
survivors [65 years (Q1–Q3: 56–78 years) vs. 58 years (Q1–
Q3: 44–70 years), p = 0.017, respectively] (Figure 1B). The age
difference between severe and non-severe cases was of borderline
significance [61 years (Q1–Q3: 48–71 years) vs. 58 years (Q1–
Q3: 43–70 years), p = 0.076] (Figure 1C), as well as the detected
weak positive correlation between age and LOH (r = 0.055,
p = 0.058) (Supplementary Appendix 4). Interestingly, patients
developing local complications were younger than those not
doing so [56 years (Q1–Q3: 43–68 years) vs. 59 years (Q1–Q3:
44–71 years), respectively, p = 0.028]. The association is true
for necrosis (p = 0.049) and fluid collections (p = 0.095), unlike
for pseudocysts (p = 0.839) (Supplementary Appendix 5). On
the contrary, patients developing systemic complications were
older than those not doing so [62 years (Q1–Q3: 50.5–74 years)
vs. 58 years (Q1–Q3: 43–70 years), respectively, p = 0.008].
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FIGURE 1 | Aging and acute pancreatitis (AP). (A) age-distribution of the study population, the red arrow indicates the median age of the population (that is,
58 years of age). (B) mortality and age (Mann–Whitney test). (C) severity and age (Mann–Whitney test).
Specifically, respiratory (p = 0.001) and heart failure (p = 0.009)
were age-dependent (Supplementary Appendix 5).
Comorbidities (CCI) Strongly Influences the
Outcomes of AP in Univariate Models
Median CCI was 2 (Q1–Q3: 0–2, range: 0–10) (Figure 2A).
Deceased had higher CCI than survivors [3 (Q1–Q3: 1–4) vs. 1
(Q1–Q3: 0–2), p = 0.001, respectively], as well as those with severe
AP [1 (Q1–Q3: 0–3) vs. 1 (Q1–Q3: 0–2), p = 0.024] compared to
those with non-severe AP, respectively (Figures 2B–C). A weak,
significant, positive correlation was detected between age and
CCI (r = 0.073, p = 0.012) (Supplementary Appendix 4).
Local complications seemed independent of CCI (p = 0.259),
as were fluid collections (p = 0.515), pseudocysts (p = 0.456),
and necrosis (p = 0.558) (Supplementary Appendix 6). Systemic
complications were associated with higher CCI (p < 0.001). This
association applies to respiratory failure (p < 0.001), as well
(Supplementary Appendix 6).
Age Correlates With CCI in a Univariate Model
We observed a moderate, positive correlation between age and
CCI (r = 0.334, p< 0.001) (Figure 3).
Analyzing the association between the individual
comorbidities (i.e., the components of CCI) and age, patients
with previous myocardial infarction, co-existing congestive
heart failure, peripheral arterial disease, and cerebrovascular
disease were significantly older than those without these
conditions (p < 0.001 for each). These associations applied
to chronic pulmonary diseases and dementia (p < 0.001 for
both), as well as to peptic ulcers/erosions (p = 0.015). Both
diabetes with and without complications were associated with
older age (p< 0.001).
Patients with malignant tumors were older (p < 0.001) but
we failed to detect this association regarding metastatic tumors
(p = 0.112), probably due to low event rates. The latter may apply
to autoimmune diseases (p = 0.961).
Interestingly, patients with mild liver disease were younger
than their healthy counterparts (p < 0.001); however, this
difference disappeared regarding moderate and severe liver
diseases (p = 0.555).
Aging and Comorbidities (CCI) Affect the Outcomes
of AP Discrepantly in Multivariate Models
Summaries of multivariate analysis are presented in Table 2
and Supplementary Appendix 7, raw data are presented in
Supplementary Appendix 8. The exclusive predictor of mortality
was a CCI ≥ 3 (ß = 1.50; OR = 4.48; CI: 1.57–12.80); in
accordance, the main predictor of severe AP was a CCI ≥ 3
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FIGURE 2 | Charlson Comorbidity Score and AP. (A) distribution of CCI in the study population, the red arrow indicates the median CCI of the population.
(B) mortality and CCI (Mann–Whitney test). (C) severity and CCI (Mann–Whitney test). CCI, Charlson Comorbidity Index.
FIGURE 3 | Correlation between age and Charlson Comorbidity Index (CCI).
Spearman’s correlation established a significant positive correlation of
moderate strength (r = 0.334, p < 0.001) between age on admission and CCI.
CCI, Charlson Comorbidity Index.
(ß = 0.74; OR = 2.10, CI: 1.08–4.09), though the middle- and
old-aged were exposed to a severe episode with a high OR
of borderline significance. Unexpectedly, the middle-aged were
more likely to spend≥9 days in hospital. Along with this, the only
predictors of local complications (including pancreatic necrosis)
was to be middle-aged (ß = 1.17; OR = 3.21, CI: 1.26–8.19). On
the contrary, the middle- and old-aged were about eight times
more likely to develop systemic complications than their younger
counterparts (β = 2.19, OR = 7.82, CI: 1.06–57.79 and β = 2.06,
OR = 8.93, CI: 1.20–66.79, respectively), though comorbidities
were important determinants, as well.
Individual Comorbidities Are Important Predictors of
the Outcomes of AP in Univariate and Multivariate
Models
Summaries of univariate and multivariate statistics of individual
comorbidities, together with raw data, are presented in
Supplementary Appendices 8–10. In univariate analysis, out
of the six comorbidities associated with higher mortality,
moderate/severe liver diseases and metastatic solid tumors
proved to be the strongest predictors (OR = 8.04, CI: 2.22–
29.13 and OR = 8.47, CI: 1.78–40.23, respectively) (Figure 4).
Peripheral vascular diseases, cerebrovascular diseases, and
diabetes without complications predicted severe AP. Patients
with mild liver diseases were two times more likely to
develop local complications, including necrotizing pancreatitis
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TABLE 2 | Joint effect of aging and comorbidities on the outcomes of AP.
Variables Deceased vs. survivors Severe vs. mild AP LOH ≤9 days vs. LOH >9 days
β OR (95% CI) p-value β OR (95% CI) p-value β OR (95% CI) p-value
Age categories
18–34 years (young-aged) NAa NAa 0.961 0 1 (reference) 0 1 (reference)
35–64 years (middle-aged) 0.76 0.76 (0.35–1.67) 0.493 2.00 7.40 (0.99–55.31) 0.051 0.62 1.86 (1.22–2.83) 0.004
>65 years (old-aged) 0 1 (ref) 1.93 6.92 (0.91–52.70) 0.062 0.40 1.50 (0.96–2.33) 0.073
Comorbidity categories
CCI = 0 (none) 0 1 (reference) 0 1 (reference) 0 1 (reference)
CCI = 1 (mild) 0.11 1.12 (0.32–3.90) 0.863 0.04 1.04 (0.52–2.08) 0.911 0.00 1.00 (0.75–1.34) 0.983
CCI = 2 (moderate) 0.09 1.10 (0.26–4.68) 0.900 −0.02 0.98 (0.45–2.24) 0.960 0.30 1.35 (0.95–1.92) 0.092
CCI > 2 (severe) 1.50 4.48 (1.57–12.80) 0.005 0.74 2.10 (1.08–4.09) 0.029 0.15 1.16 (0.83–1.62) 0.387
Red highlights indicate p < 0.05, orange highlights indicate p < 0.10 but ≥0.05. AP, acute pancreatitis; Charlson Comorbidity Index; CI, confidence interval; LOH, length
of hospitalization; NA, not applicable; OR, odds ratio. aanalysis is impossible due to zero events.
(OR = 1.86, CI: 1.25–2.75). Congestive heart failure, peripheral
vascular diseases, cerebrovascular diseases, chronic pulmonary
diseases, and diabetes without complications were associated
with a higher rate of systemic complications. Preexisting
cardiovascular, renal, and pulmonary diseases predicted the
development of respiratory, heart, and renal decompensation,
respectively. Interestingly, pre-existing moderate/severe liver
diseases and malignant tumors were strongly associated with
cardiac decompensation (OR = 7.16, CI: 1.55–33.21 and
OR = 4.09, CI: 1.32–12.64, respectively). Multivariate analysis
only minimally changed the direction of main associations.
DISCUSSION
Summary of Findings
We aimed to clarify whether aging or comorbidities are decisive
for determining the outcomes of AP. All the outcomes, except for
local complications, proved to be dependent on both age and CCI
in univariate analysis. As opposed to this, multivariate analysis
revealed that patients suffering from severe comorbidities were
about 4.5 times more likely to have a fatal episode of AP and about
two times more likely to develop severe AP than those having no
comorbidities, whereas age predicted these outcomes with high
OR and borderline significance. In contrast, the middle- and old-
aged (but not those with severe comorbidities) were more likely
to spend at least 9 days in hospital, as compared to their young
counterparts. Moreover, aging and comorbidities influenced the
development of local and systemic complications in a completely
different manner.
Frequency of comorbidities and distribution of age were
similar in our cohort of AP cases to that of the large series in the
literature (Frey et al., 2007; Singla et al., 2009; Murata et al., 2011,
2015; Akshintala et al., 2013; McNabb-Baltar et al., 2014).
Although mortality of populations is widely reported, studies
on the effect of aging yielded controversial results. Some indicated
that each year increase in age may result in an OR = 1.01–1.04
(p < 0.05) increase in mortality (Singla et al., 2009; Akshintala
et al., 2013; McNabb-Baltar et al., 2014); however, the detection of
FIGURE 4 | Forest plot on the effect of individual comorbidities on mortality.
95% confidence intervals did not cross the boundary of significance (red,
vertical line at an odds ratio of (1) regarding six comorbid conditions:
congestive heart failure, peripheral vascular disease, cerebrovascular disease,
moderate/severe renal disease, moderate/severe liver disease, and metastatic
tumor (asterisks indicate a p-value less than 0.05). These comorbidities were
associated with higher mortality.
this statistically significant but probably clinically less prominent
increment might have been attained due to large sample sizes.
High mortality of older age groups is frequently reported (Frey
et al., 2007; Murata et al., 2011; Mendez-Bailon et al., 2015), as are
the effects of severe comorbidities: they are strong, independent
predictors of mortality in AP (Frey et al., 2007; Singla et al.,
2009; Murata et al., 2011, 2015; Akshintala et al., 2013; McNabb-
Baltar et al., 2014; Mendez-Bailon et al., 2015; Lee et al., 2016),
as confirmed by our study, as well. Our results are in line with
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FIGURE 5 | Model for the joint effect of aging and comorbidities on mortality and severity. (A) The excess in mortality in the elderly is likely to be explained by the
increment in comorbidities with aging. (B) In contrast, age seems to be the strongest predictor of the severity of AP, whereas comorbidities have a less prominent
effect.
previous findings in a cohort of patients over 70 years stating
that pre-existing cardiovascular, malignant, and renal diseases
predicted mortality (Murata et al., 2015).
No studies investigated the effects of comorbidities on AP
severity graded by the revised Atlanta criteria (Sarr, 2013). In our
study, patients with severe AP were older and had higher CCI
than those developing moderate AP. Besides that a CCI ≥ 3 is an
independent predictor of severe AP, middle and old age should be
considered a strong risk factor in multivariate analysis (including
age and CCI categories).
The middle- and old-aged patients were more likely to
stay ≥9 day in hospital as compared to younger counterparts.
We found no association between LOH and comorbidities,
which may oppose previous research (Murata et al., 2011, 2015;
Francisco et al., 2013). A possible explanation for this discrepancy
may be that we handled LOH as a dichotomous variable in
multivariate analysis due to non-normal distribution of data. No
studies have analyzed the effect of individual comorbidities on
LOH; in our cohort of patients myocardial infarction, mild liver
diseases as well as middle and old age predisposed to longer LOH.
Interestingly, patients with local complications and necrosis
were younger but do not have higher CCI than those not
developing them. Only being middle-aged was an independent
predictor of local complications and necrosis. Two small studies
reported non-significant associations between comorbidities and
local complications (Uomo et al., 1998; Weitz et al., 2016).
One study reported on 2-week organ failure, which found
that only the number of comorbidities, but not age, was a
significant predictor (Frey et al., 2007). On the contrary in
our study, the strongest predictor of organ failure was aging:
the middle- and old aged were about 8 times more likely to
develop organ failure than their younger counterparts, while
having severe comorbidities proved to be a weak but significant
predictor, as well.
Strengths and Weaknesses
Our study has several strengths. First of all, this is the first
report analyzing the joint effect of aging and comorbidities on AP
severity and local complications in a non-selected cohort of AP
cases with multivariate statistics. Secondly, manual assessment of
CCI by a trained investigator provides a sufficient accuracy and
might be superior in homogeneity over claims data (Kieszak et al.,
1999) upon which most population-based studies rely. Third,
precise data collection and consistent data management of the
AP Registry with uniform recording of diagnosis, severity, and
complications across centers improve the reliability of data and,
therefore, strengthen our conclusions (Sarr, 2013).
However, authors must acknowledge that the study is limited
by the number of reasons. Data collected are limited to adult
(18–95 years). Despite the high case number, event numbers
concerning some outcomes limited the analysis. To overcome
this, we merged similar items of CCI (e.g., malignant tumors)
when imputing them in multivariate models, as seen in other
works (Murata et al., 2015). Distribution of continuous variables
proved to be non-normal so that multivariate regression was
not performed in terms of LOH. Instead, a dichotomized
logistic regression model was used. Similarly, the non-normal
distribution of age and CCI forced us to set up age and
comorbidity categories in multivariate analysis. Despite the
four-level data checking system, imprecision of data recording
cannot be excluded.
CONCLUSION
Our results confirm that both aging and comorbidities modify
the outcomes of AP, however, discrepantly. The increment in
mortality associated with an older age in the meta-analysis
of Marta et al. might be explained by the additive effects of
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comorbidities (Figure 5). Taken together, these results support
that CCI, together with age, should be incorporated into the
predictive scores in AP to increase the accuracy of prediction.
Studies validating the implementation of CCI-based predictive
scores are awaited.
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